Skip to main content

Olezarsen FDA Approval Status

FDA Approved: No
Generic name: olezarsen

Development timeline for olezarsen

DateArticle
Apr  7, 2024Ionis Presents Positive Results from Phase 3 Balance Study of Olezarsen for Familial Chylomicronemia Syndrome
Jan 31, 2023Ionis Receives FDA Fast Track Designation for Olezarsen in Patients with Familial Chylomicronemia Syndrome
Nov  2, 2021Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer